# Second Study on Cardio-neuromodulation in Humans

> **NCT02954666** · NA · COMPLETED · sponsor: **Imelda Hospital, Bonheiden** · enrollment: 50 (actual)

## Conditions studied

- Cardiac Disease
- Syncope
- Syncope, Vasovagal
- Sick Sinus Syndrome

## Interventions

- **DEVICE:** radio-frequency ablation

## Key facts

- **NCT ID:** NCT02954666
- **Lead sponsor:** Imelda Hospital, Bonheiden
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-10
- **Primary completion:** 2020-04-01
- **Final completion:** 2020-05-11
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2021-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02954666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02954666, "Second Study on Cardio-neuromodulation in Humans". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02954666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*